Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe toxic hepatitis during flutamide (Eulexin) treatment].

S Møller, P Iversen

    Ugeskrift for Laeger
    |January 16, 1989
    PubMed
    Summary

    Flutamide, used for prostate cancer, can cause severe toxic hepatitis. Discontinuing the drug reversed liver failure, highlighting its potential hepatotoxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pelvic fracture related hematoma - emergency treatment and bleeding control.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2026
    Same author

    Radio-Frequency Charge Detection on Graphene Electron-Hole Double Quantum Dots.

    Nano letters·2025
    Same author

    Clinical evaluation of the ADVIA Centaur XPT chemiluminescent immunoassay for equine insulin measurement.

    Journal of equine veterinary science·2025
    Same author

    Electric-Field-Tunable Spin-Orbit Gap in a Bilayer Graphene/WSe<sub>2</sub> Quantum Dot.

    Nano letters·2025
    Same author

    [S1 guideline on sustainability in intensive care and emergency medicine].

    Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025
    Same author

    Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma.

    Journal of autoimmunity·2025

    Area of Science:

    • Hepatology
    • Oncology
    • Pharmacology

    Background:

    • Metastatic prostatic cancer treatment often involves hormonal therapy.
    • Flutamide is a non-steroidal anti-androgen commonly used in combination therapy.
    • LHRH analogues like goserelin are frequently used alongside flutamide.

    Observation:

    • A patient with metastatic prostate cancer developed severe toxic hepatitis.
    • The patient was undergoing three months of combination therapy with flutamide and goserelin.
    • Symptoms included jaundice, ascites, and severe encephalopathy.

    Findings:

    • Discontinuation of flutamide led to the reversal of severe liver failure.
    • This case suggests flutamide is a potential hepatotoxin.
    • Similar, less severe adverse reactions have been documented in medical literature.

    Implications:

    • Clinicians should consider flutamide as a potential cause of toxic hepatitis in patients.
    • Monitoring liver function is crucial during flutamide treatment for prostate cancer.
    • Further investigation into flutamide-induced hepatotoxicity is warranted.

    Related Experiment Videos